Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SSTR4 | P31391 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3630902 | 0.84 | LMNA (0.32) | LMNAHSD17B10 | |
| Hydrochloric Acid SCHEMBL31255580 | 0.82 | LMNA (0.32) | LMNAHSD17B10 | |
| SCHEMBL19063653 | 0.73 | KDM4E (0.33) | — | |
| SCHEMBL1711675 | 0.72 | CPN1 (0.35) | LMNAHSD17B10 | |
| SCHEMBL17076623 | 0.72 | ALOX5 (0.35) | LMNAHSD17B10 | |
| SCHEMBL3465229 | 0.70 | SLC6A2 (0.36) | SSTR4 | |
| SCHEMBL14830518 | 0.69 | ATM (0.32) | — | |
| SCHEMBL28345899 | 0.69 | ATM (0.32) | — | |
| SCHEMBL523966 | 0.69 | — | — | |
| SCHEMBL28345897 | 0.69 | ATM (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100016400-A1 | AZABICYCLIC MUSCARINIC RECEPTOR ANTAGONISTS | RANBAXY LABORATORIES LIMITED (IN) | 2010-01-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100016400-A1 | AZABICYCLIC MUSCARINIC RECEPTOR ANTAGONISTS | CHRM3, CHRM5, CHRM2 | SSTR4 587/4885LMNA 4055/4885HSD17B10 2788/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.